NewAmsterdam Pharma Company NV - Warrants (15/11/2027) (NAMS+) Q3 2022 Earnings

18OctExpected
Q4 2021
Q1 2022
Q2 2022
Q3 2022
-1.14
-0.73
-0.33
0.08

Details

Expected EPS
-1.14
Actual EPS
-0.2693
Surprise EPS
0.87
Surprise Percent
+76.38%

Description

NewAmsterdam Pharma Company NV - Warrants (15/11/2027) (NAMS+) has reported earnings of -0.2693 per share for Q3 2022.

0 Comments

Share your thoughts